Medical Mycology

Papers
(The H4-Index of Medical Mycology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis78
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management68
S5.1b Antifungal r esistance57
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants46
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India46
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?45
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis44
P216 Rare isolates from subcutaneous mycotic lesions; A study from tertiary care center in Chhattisgarh, India44
P196 A rare presentation of subcutaneous Entomophthoramycosis42
P361 Demystifying the NIH grant application process for international investigators41
P335 Genome plasticity in Candida albicans : acutting-edge strategy for evolution, adaptation, and survival40
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain36
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis31
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study30
S1.3c Diversity and hybridization in Malassezia furfur30
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis26
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa26
P019 A 5-year study on prevalence and molecular determinants of fluconazole -resistance in C. parapsilosis spp. complex26
Novel in vivo observations of luliconazole 5% nail solution for onychomycosis: An ultrastructural study24
Clinical characteristics and outcomes of pancreatic fungal infection in patients with necrotizing pancreatitis24
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?24
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives23
Fungal diagnostics capacity in Malaysia: A survey across 48 laboratories22
0.092390775680542